Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

FRA:BT3 (USA)  
€ 0.88 (+0.57%) Jun 7
At Loss
P/B:
2.53
Market Cap:
€ 168.21M ($ 180.88M)
Enterprise V:
€ 131.13M ($ 141.02M)
Volume:
-
Avg Vol (2M):
759.00
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
759.00

Lineage Cell Therapeutics Inc Valuation Measures